Education
About Us
Working with TipRanks
Follow Us
Alistair Milnes Insider Profile
4 Followers
Alistair Milnes, COO at Bicycle Therapeutics, holds 95.50K shares in Bicycle Therapeutics (Ticker: BCYC), holds ― shares in Femasys (Ticker: FEMY). Most recently, Alistair Milnes Sold ― shares of Bicycle Therapeutics on Jul 07, 2025 for an estimated value of $15.33K.
Profitable Transactions
7 out of 11 Profitable Transactions
Average Return
+27.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Apr 05, 2024 - Apr 05, 2025
Return:+69.60%
The most profitable trade made by Alistair Milnes
Alistair Milnes's Trading History
Bicycle Therapeutics
Jul 07, 2025
COO
Informative Sell
15.33K
$710.53K
Femasys
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Alistair Milnes's performance on stock
You May Also Like
Alistair Milnes insider profile FAQ
What is the percentage of profitable transactions made by Alistair Milnes?
The percentage of profitable transactions made by Alistair Milnes is 64%.
What is the average return per transaction made by Alistair Milnes?
The average return per transaction made by Alistair Milnes is 27.30%.
What stocks does Alistair Milnes hold?
Alistair Milnes holds: BCYC, FEMY stocks.
What was Alistair Milnes’s latest transaction?
Alistair Milnes latest transaction was an Informative Sell of $15.33K.
What was Alistair Milnes's most profitable transaction?
Alistair Milnes’s most profitable transaction was an Informative Sell of BCYC stock on April 5, 2024. The return on the trade was 69.60%.
What is Alistair Milnes's role in Bicycle Therapeutics?
Alistair Milnes's role in Bicycle Therapeutics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.